NCT06259890Recruiting
Influence of Sodium Intake in spondyLoarthriTes
Sodium Intake in spondyLoarthriTes: Analysis of the Influence on the Activity of the Disease and the Therapeutic Response to Anti IL-17A Agents.
Source: ClinicalTrials.gov · Last updated 9 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of the SALT study is to analyze the relationship between dietary sodium intake and disease activity in patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- First submitted
- 31 Jan 2024
- Start date
- 30 Jan 2024
- Primary completion date
- Nov 2026
- Lead sponsor
- Centre Hospitalier Universitaire de Besancon
- Diseases
- Psoriasis, Psoriatic arthritis
- NCT number
- NCT06259890
What you commit to
- Study type: Interventional
- Planned participants: 250
- From 30 Jan 2024 to the primary completion date, Nov 2026
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patient treated by cyclosporine, diuretics, angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists.
- current treatment with an anti-IL-17A agent (secukinumab or ixekizumab or bimekizumab or brodalumab) or with an anti-IL23 agent (ustekinumab, guselkumab, risankizumab or tildrakizumab) or previous treatment less than 6 months old.
- patients on systemic corticosteroids with corticosteroid therapy \> 10 mg prednisone equivalent
Other
- pregnant woman
Who the study is looking for
- patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis
- women who have been menopausal for at least 24 months, surgically sterilized, or, for women of childbearing potentiale, use an effective method of contraception (oral contraceptives, contraceptive injections, intrauterine devices, double-barrier method, contraceptive patches)
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Besançon Coordinator of this site? Confirm its status | Besançon | France | Recruiting |
| CHD Vendée Coordinator of this site? Confirm its status | La Roche-sur-Yon | France | Recruiting |
| Chu St-Etienne Coordinator of this site? Confirm its status | Saint-Etienne | France | Recruiting |
| Hôpital Nord Franche-Comté Coordinator of this site? Confirm its status | Trévenans | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.